Lupin wins USFDA nods for Liraglutide, Glucagon Injectable Products Ruchika Sharma24 July 2025 11:14 AM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated...
Lupin receives USFDA observations for two Pithampur manufacturing units Ruchika Sharma18 July 2025 11:57 AM ISTMumbai: Pharma major Lupin has received multiple observations from the U.S. Food and Drug Administration (USFDA) following inspections at two of...
Lupin arm Dabhasa facility gets GMP certification from TGA Australia Ruchika Sharma18 July 2025 11:38 AM ISTMumbai: Global pharma major Lupin Limited has announced that the API manufacturing facility of its wholly owned subsidiary, Lupin Manufacturing...
Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension, 0.5% in US Ruchika Sharma16 July 2025 5:04 PM ISTMumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States,...
Lupin, Zentiva ink pact to commercialize arthritis drug Certolizumab Pegol Ruchika Sharma9 July 2025 2:58 PM ISTIt is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis.
Lupin rolls out Nasal spray for rhinorrhea relief in US Ruchika Sharma4 July 2025 3:23 PM ISTMumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. ...
Lupin secures USFDA approval for Loteprednol Etabonate Ophthalmic Gel Ruchika Sharma1 July 2025 4:38 PM ISTThe product is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.
Lupin carves out consumer healthcare business Ruchika Sharma1 July 2025 4:05 PM ISTMumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, LupinLife Consumer...
Lupin rolls out constipation drug Prucalopride in US after USFDA nod Ruchika Sharma26 Jun 2025 2:48 PM ISTMumbai: Global pharma major Lupin Limited has launched Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following the recent approval...
USFDA okays Lupin Prucalopride Tablets for chronic idiopathic constipation Ruchika Sharma25 Jun 2025 12:56 PM ISTMumbai: Global pharma major Lupin Limited has received a green light from the United States Food and Drug Administration (U.S. FDA) for its...
Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER Ruchika Sharma7 Jun 2025 5:24 PM ISTMumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...
Lupin to present data from Phase 1a trial evaluating LNP7457 at ASCO annual meeting Ruchika Sharma27 May 2025 12:00 PM ISTMumbai: Global pharma major Lupin Limited will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American...
